[smart_track_player url=”https://media.blubrry.com/darshantalks/content.blubrry.com/darshantalks/ep159_pharmacogenomics_in_2020.mp3″ title=”Pharmacogenomics in 2020″ color=”#FF5722″ social_linkedin=”true” social_email=”true” tweet_text=”Listen to this @darshantalks podcast on #Pharmacogenomics in 2020!”]
[fusebox_transcript]
How will Pharmacogenomics look in 2020? Is your company sufficiently prepared? Join FDA regulatory attorney Darshan Kulkarni as he discusses how pharmacogenomics may change in 2020, and whether your clinical trials may be affected.
